Driving Innovation in Diagnostics
Established in 2021 in Bradenton, FL, NanoDx is dedicated to providing high-quality reagents, antibodies, nanomaterials, and comprehensive products and services for research, academia, and industry partners worldwide.
2021
Founded
50+
Partners Served
12+
Team Members
Global
Reach
Our Mission
To accelerate scientific discovery and clinical translation by delivering reliable, reproducible nanomaterials, reagents, and assay development services — enabling our partners to bring better diagnostics to the people who need them.
We believe that great science happens at the intersection of rigorous engineering and deep collaboration. That's why every NanoDx project is treated as a partnership, not a transaction.
Scientific Excellence
Rigorous QC and reproducibility in every batch.
Partnership
We collaborate closely to solve tough problems.
Innovation
Continuous investment in new materials & methods.
Global Reach
Serving academic and industrial partners worldwide.
Our Leadership
A team with deep experience across nanomaterials, diagnostics, software, and financial strategy.
Priyanka Dubey
Chief Executive Officer
Priyanka Dubey is a dynamic and multifaceted leader, currently serving as the CEO of NanoDx.
With a unique blend of expertise spanning software engineering and human resources, Priyanka brings a holistic and strategic approach to the company's vision and operations.
Her leadership is instrumental in guiding NanoDx's mission to provide high-quality reagents, antibodies, and nanomaterials to partners worldwide.
What We Do
A snapshot of our product lines and development services.
Gold Nanoparticles
Custom sizes, surfaces, and conjugates.
Silica Nanoparticles
Dye-doped and plain, narrow size distribution.
Magnetic Particles
For separation, extraction, and detection.
Fusion Particles
Multi-modal cores for advanced assays.
Immunoassay Development
ELISA, CLIA, and nano-immunoassay formats.
Lateral Flow Development
Rapid immunochromatographic assays.
Surface Coatings
SAMs, polymers, and plasma treatments.
Custom Antibodies
Polyclonal and monoclonal development.
Biosensor Prototyping
Electrochemical, optical, and SPR platforms.
Our Journey
Key milestones since our founding.
2021
NanoDx Corp founded in Bradenton, FL with a focus on nanomaterials for diagnostics.
2022
Launched our gold and silica nanoparticle product lines with full QC documentation.
2023
Expanded into immunoassay and lateral-flow development services for industry partners.
2024+
Serving academic and industrial customers across North America, Europe, and Asia.
Partner With NanoDx
From custom nanomaterials to full assay development — let's build something together.
Contact Us